Allogeneic hematopoietic stem cell transplantation in non‐Hodgkin lymphoma in Switzerland, 30 years of experience: Sooner is better

Due to relatively high nonrelapse mortality (NRM), allogeneic hematopoietic stem cell transplantation (allo‐HSCT) in non‐Hodgkin's lymphoma (NHL) remains the ultimate line of treatment but the only curable approach in a setting of relapse/refractory disease. Here, we conducted a retrospective,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebmann, Ekaterina, Nabergoj, Mitja, Grandjean, Bastien, Stakia, Paraskevi, Stern, Alix, Medinger, Michael, Masouridi‐Levrat, Stavroula, Dantin, Carole, Schanz, Urs, Baldomero, Helen, Passweg, Jakob, Nair, Gayathri, Rovo, Alicia, Chalandon, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928653/
https://www.ncbi.nlm.nih.gov/pubmed/36819159
http://dx.doi.org/10.1002/jha2.614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928653/
https://www.ncbi.nlm.nih.gov/pubmed/36819159
http://dx.doi.org/10.1002/jha2.614

Ejemplares similares